Molecular cascades and cell type-specific signatures in ASD revealed by single-cell genomics.
Brie WamsleyLucy BicksYuyan ChengRiki KawaguchiDiana QuinteroMichael MargolisJennifer GrundmanJianyin LiuShaohua XiaoNatalie HawkenSamantha MazariegosDaniel H GeschwindPublished in: Science (New York, N.Y.) (2024)
Genomic profiling in postmortem brain from autistic individuals has consistently revealed convergent molecular changes. What drives these changes and how they relate to genetic susceptibility in this complex condition are not well understood. We performed deep single-nucleus RNA sequencing (snRNA-seq) to examine cell composition and transcriptomics, identifying dysregulation of cell type-specific gene regulatory networks (GRNs) in autism spectrum disorder (ASD), which we corroborated using single-nucleus assay for transposase-accessible chromatin with sequencing (snATAC-seq) and spatial transcriptomics. Transcriptomic changes were primarily cell type specific, involving multiple cell types, most prominently interhemispheric and callosal-projecting neurons, interneurons within superficial laminae, and distinct glial reactive states involving oligodendrocytes, microglia, and astrocytes. Autism-associated GRN drivers and their targets were enriched in rare and common genetic risk variants, connecting autism genetic susceptibility and cellular and circuit alterations in the human brain.
Keyphrases
- single cell
- autism spectrum disorder
- rna seq
- genome wide
- high throughput
- copy number
- intellectual disability
- attention deficit hyperactivity disorder
- dna methylation
- neuropathic pain
- gene expression
- spinal cord
- transcription factor
- stem cells
- functional connectivity
- dna damage
- single molecule
- bone marrow
- inflammatory response
- resting state
- mesenchymal stem cells
- multiple sclerosis
- oxidative stress
- blood brain barrier
- working memory
- cerebral ischemia